2017-07-25T11:36:37-05:00 2016-09-30 ERNST & YOUNG US LLP 200 CLARENDON STREET BOSTON MA 021165072 990 2015-10-01 043102433 Dana-Farber Inc % STEVEN CONNOLLY DANA 6176323000 450 Brookline Ave BP418 Boston MA 02215 MICHAEL RENEY CFO 6176323000 2017-07-24 BARBARA E HUNT P00916443 6172662000 2015 2021-01-29 14:40:06Z Laurie H Glimcher MD 450 BROOKLINE AVE BP418 BOSTON MA 02215 184374909 false X N/A X 1990 MA THE PURPOSE & ACTIVITIES AT DANA-FARBER, INC, ARE TO PROMOTE & SUPPORT THE EXEMPT MISSIONS OF DANA-FARBER CANCER INSTITUTE AND TO PROVIDE INVESTMENT MANAGEMENT SERVICES. 4 3 0 0 561709 0 0 0 0 47883024 25181104 0 0 47883024 25181104 0 0 0 0 0 0 0 0 0 3831983 4675222 3831983 4675222 44051041 20505882 963288515 1048902344 963288515 1048902344 0 0 THE PURPOSE & ACTIVITIES AT DANA-FARBER, INC. ARE TO PROMOTE & SUPPORT THE EXEMPT MISSIONS OF DANA-FARBER CANCER INSTITUTE AND TO PROVIDE INVESTMENT MANAGEMENT SERVICES TO SUPPORT SUCH PURPOSES. false false 0 0 0 Provides support to Dana-Farber Cancer Institute through investment management services. 0 true false false false false false false false false true false true false false true false false true false false true false false false false false false false false true false false false false false false false false false false false false false true true false false false true 0 0 0 true true false false false false false false false false false X 4 3 true false false false false false false true true false false true true true true true true false false false MA X STEVEN CONNOLLY 6176323000 C/O DFCI 450 BROOKLINE BP418 BOSTON MA 02215 Joshua Bekenstein Chairman & Trustee 2.0 2.0 X X 0 0 0 Edward J Benz Jr MD President, CEO, Trustee 2.0 50.0 X X 0 1309437 241970 Brian Knez Vice Chair&Treasurer, Trustee 2.0 2.0 X X 0 0 0 Robert Stansky Trustee 1.0 1.0 X 0 0 0 Richard S Boskey Esq Assistant Secretary 2.0 50.0 X 0 557270 67180 Neal J Curtin Esq Secretary, 1.0 1.0 X 0 0 0 Michael Reney Assistant Treasurer 2.0 50.0 X 0 117833 372 Karen Bird Former Officer 2.0 50.0 X 0 407417 54961 0 2391957 364483 0 true true false Baupost Value Partners IV LP 10 Saint James Avenue Suite 1700 BOSTON MA 02116 INVESTMENT Advisory 429491 Cambridge Associates 100 Summer St 13 BOSTON MA 02110 Consulting Fees 835750 Silchester International Investors 780 Third Ave 42ND FL NEW YORK NY 10017 INVESTMENT Advisory 313363 Westwood Global Investments LLC One Financial Center Suite 1620 BOSTON MA 02111 INVESTMENT Advisory 263891 MFS INTL GROWTH LLC 30 Dan Rd CANTON MA 02021 investment advisory 266437 18 0 0 3927440 561709 3365731 0 0 0 0 0 180447470 159193805 21253665 21253664 21253664 0 0 0 0 25181104 561709 24619395 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4675222 4675222 0 0 0 0 0 0 0 0 0 0 0 0 0 4675222 0 4675222 0 0 0 12294846 14435901 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 245457678 247259348 705535991 787207095 0 0 0 0 0 0 963288515 1048902344 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 963288515 1048902344 963288515 1048902344 0 0 963288515 1048902344 X 20505882 59733345 -80239227 X false true X true false X X X 1 DANA-FARBER CANCER INSTITUTE INC 042263040 3 true 0 0 1 true false false false false false false false false false false false false false false true false Part I, LINE 11H Dana-Farber, Inc. ("DFI") supports only Dana-Farber Cancer Institute, Inc. ("DFCI") by providing investment management services. The provision of investment management services to DFCI is DFI's sole activity. COMINGLED FUNDS 220269030 F HEDGE FUNDS 389244517 F PRIV EQUITY & VENTURE CAP FUND 119892345 F REAL ESTATE FUNDS 38256026 F NATURAL RESOURCES 19545177 F 787207095 0 HELD AS AGENT FOR DFCI 1048902344 1048902344 Central America and the Caribbean Investments 316078362 Sub-Saharan Africa Investments 2899488 East Asia and the Pacific Investments 490907 Europe (Including Iceland and Greenland) Investments 1079688 320548445 320548445 true false false false true false false true false false false false false false false Edward J Benz Jr MD President, CEO, Trustee 0 910909 0 294193 0 104335 0 221671 0 20299 0 1551407 0 Karen Bird Former Officer 0 345728 0 58380 0 3309 0 28200 0 26761 0 462378 0 Richard S Boskey Esq Assistant Secretary 0 453010 0 69567 0 34693 0 37800 0 29380 0 624450 0 Schedule J, Part I Line 4b The following individuals participate in DFCI's 457(f) plan; taxable amounts are included in reportable compensation in Schedule J, Part II, Column (B)(iii): Name: Benz, Edward J. JR., MD 81,794 Boskey, Richard S., ESQ 24,848 Form 990, Part VI Line 2 Dr. Edward Benz was employed by and entity over which the trustees of DFI were also trustees. Part VI line 7a and 7b DFCI is the sole corporate member of DFI and DFCI as sole member has certain governance decisions reserved to it under state law. Part VI Line 11 Process used to review the Form 990 The Form 990 is prepared by the Tax Department of DFCI and independently reviewed by Ernst & Young LLP for technical tax issues. After the Tax Department and Ernst & Young finalize the returns, The Chief Financial Officer of DFCI meets with the Tax Department to review the tax return. If any changes need to be made, the Tax Department will make the changes in accordance with the CFO. After the CFO approves the return, certain sections are taken to Board Committees for a more detailed analysis. For example, the Board Compensation Committee reviews all information related to compensation in Part VII and Schedule J. Once the return has been through the committees who review certain sections, the tax return is presented to the Audit Committee for review and approval. After the audit committee approves the tax return, an electronic message is sent to all Board members with a secured link to the tax return. The Board has the opportunity to review the return and if any issues arise, they can bring them to the appropriate executive management individuals. The return is only filed after each of the steps in the review process is complete. Form 990, Part VI, Line 12c Monitoring & Enforcement of Conflict of Interest Policy The Office of General Counsel, the Assistant Secretary of the Board, and the Tax Department drafts a Conflict of Interest Disclosure Questionnaire each year and has all trustees and officers fill out a questionnaire in regards to their personal situation and personal and business relationships. The Assistant Secretary compiles the list of Disclosures and gathers financial data from the Accounts Payable and Payroll Department for all organizations, employees, independent contractors, and other miscellaneous transactions which were disclosed by all individuals. Once all of this information is complied, the Office of General Counsel and the Tax Department goes through each transaction and disclosure to determine what needs to be disclosed on the tax return. The Tax Department and the Office of General Counsel also discusses if there are any other known transactions that have not been disclosed. If there are any questions regarding such situation, the Office of General Counsel and the Assistant Secretary will discuss the questions with the individual trustees or officers involved. In addition the process described above, the governance committee of the board of directors annually reviews the conflict of interest disclosures and they address any issues that may arise. The governance committee is also responsible to bring any major issues related to the conflict of interest policy to the executive committee and the entire Board if deemed necessary. Per DFCI and Affiliate's conflict of interest policy, in order to avoid a conflict of interest or an appearance of a conflict of interest: 1. A Trustee should not participate in a vote on a transaction in which the Trustee or family member has a financial interest and should disclose any potential conflict before DFI acts on the transaction. 2. A Trustee, a member of his or her family, or an entity with which one or more of them has a material interest, may not do business with DFI unless expressly authorized by DFI after full disclosure. 3. A Trustee should fully disclose his or her association (including employment, consulting, or membership on a governing board by the Trustee or a family member) with an entity that competes with or has interests conflicting with those of DFI and should refrain from participating in any vote of other the organization if the vote affects DFI. Part VI, Question 19 Governing Documents We currently provide the governing documents upon request. The Governing Documents are also available to the Public on the Secretary of the Commonwealth's website. Conflict of Interest Policy DFI's Conflict of Interest Policy can be found within Dana-Farber Cancer Institute, Inc. & its Affiliates Code of Conduct, which is available on its website. Financial Statements - The organization uses the services of Digital Assurance Certification LLC (DAC) to report annual audited financial statements and other relevant organizational information as required by certain regulatory and tax laws. DAC is a website (www.dacbond.com) free to the public that publishes tax-exempt bond issuers' financial and legal documents such as the Audited Financial Statements. Fiscal Year 2001 through the latest issue date of the Audited Consolidated Financial Statements for Dana-Farber Cancer Institute, Inc. and Dana-Farber, Inc. can be found on the DAC website. Form 990, Part XI, Line 5 Other Changes in net assets include: Transfer of net assets to DFCI ($80,239,227) Part XII, Line 2D DFI is included in the consolidated Audited Financial Statements of DFCI. Dana-Farber Cancer Institute Inc 450 Brookline Avenue BP418 Boston MA 02215 042260340 Cancer Care MA 501(c)(3) 7 NA false Dana-Farber Trust Inc 450 Brookline Ave BP418 Boston MA 02215 300195757 Rec. R/E Gift MA 501(c)(3) 11A, Type 1 DFCI true FRIENDS OF DANA-FARBER CANCER INSTITUTE 450 BROOKLIKE ROAD BP418 BOSTON MA 02215 371613621 FUNDRAISING MA 501(c)(3) 11A, TYPE 1 DFCI true Dana-Farber Cancer Care Network Inc 450 Brookline Ave BP418 Boston MA 02215 465138314 Cancer Care MA 501(c)(3) 11A, TYPE 1 DFCI true false false false false false false false false false false false false false false false false false true true Dana-Farber Cancer Institute Inc R 217885896 CASH Dana-Farber Cancer Institute Inc S 37078683 CASH